115 related articles for article (PubMed ID: 30365996)
1. High-throughput sequencing of the T-cell receptor β chain gene distinguishes 2 subgroups of cutaneous T-cell lymphoma.
Wang J; Rea B; Haun P; Emerson R; Kirsch I; Bagg A
J Am Acad Dermatol; 2019 Apr; 80(4):1148-1150.e1. PubMed ID: 30365996
[No Abstract] [Full Text] [Related]
2. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma.
Rea B; Haun P; Emerson R; Vignali M; Farooqi M; Samimi S; Elenitsas R; Kirsch I; Bagg A
J Clin Pathol; 2018 Sep; 71(9):814-820. PubMed ID: 29636372
[TBL] [Abstract][Full Text] [Related]
3. Beyond clonal detection: defining the T-cell clone.
Guitart J
Arch Dermatol; 2005 Sep; 141(9):1159-60. PubMed ID: 16172316
[No Abstract] [Full Text] [Related]
4. Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma.
Zimmermann C; Boisson M; Ram-Wolff C; Sadoux A; Louveau B; Vignon-Pennamen MD; Rivet J; Cayuela JM; Dobos G; Moins-Teisserenc H; Roelens M; Gruber A; Lebbé C; Bagot M; Battistella M; Mourah S; de Masson A
Br J Dermatol; 2021 Sep; 185(3):679-680. PubMed ID: 33942285
[No Abstract] [Full Text] [Related]
5. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
[TBL] [Abstract][Full Text] [Related]
6. Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma.
Gibbs JD; Ma S; Kim A; Seminario-Vidal L; Sokol L; Zhang H; Zhang X; Sagatys E; Chen PL; Messina JL
Oncol Rep; 2021 Jan; 45(1):349-358. PubMed ID: 33416132
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor-gamma gene analysis of CD30+ large atypical individual cells in CD30+ large primary cutaneous T cell lymphomas.
Gellrich S; Wilks A; Lukowsky A; Wernicke M; Müller A; Marcus Muche J; Fischer T; Jasch KC; Audring H; Sterry W
J Invest Dermatol; 2003 Apr; 120(4):670-5. PubMed ID: 12648233
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
[TBL] [Abstract][Full Text] [Related]
9. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous T-cell-rich B-cell lymphoma: clinically distinct from its nodal counterpart?
Li S; Griffin CA; Mann RB; Borowitz MJ
Mod Pathol; 2001 Jan; 14(1):10-3. PubMed ID: 11211304
[TBL] [Abstract][Full Text] [Related]
12. A Case of Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma Misdiagnosed as Febrile Ulceronecrotic Mucha-Habermann Disease.
Sheng N; Li Z; Su W; Liu W; Zong W; Wang B; Feng S
Acta Derm Venereol; 2016 Jan; 96(1):136-7. PubMed ID: 26039505
[No Abstract] [Full Text] [Related]
13. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
14. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
[TBL] [Abstract][Full Text] [Related]
15. Serological immunomarkers in cutaneous T cell lymphoma.
Hassel JC; Meier R; Joller-Jemelka H; Burg G; Dummer R
Dermatology; 2004; 209(4):296-300. PubMed ID: 15539892
[TBL] [Abstract][Full Text] [Related]
16. TCRVb repertoire abnormalities in patients with cutaneous T-cell lymphoma.
Papadavid E; Kapsimali V; Psarra A; Antoniou C; Papasteriadi C; Ekonomidou J; Anagnostou D; Nikolaou V; Kounaki D; Dalamaga M; Bamia C; Stratigos A; Stavrianeas N; Katsambas A
Leuk Lymphoma; 2009 Jan; 50(1):130-2. PubMed ID: 19152167
[No Abstract] [Full Text] [Related]
17. Pathobiology of CD30+ cutaneous T-cell lymphomas.
Kadin ME
J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
[TBL] [Abstract][Full Text] [Related]
18. Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma.
Litvinov IV; Zhou Y; Kupper TS; Sasseville D
Leuk Lymphoma; 2013 Mar; 54(3):653-4. PubMed ID: 22856870
[No Abstract] [Full Text] [Related]
19. Cutaneous T-cell lymphoma: from genetics to clinical practice.
Dummer R; Zucca E
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):7-8. PubMed ID: 17474352
[No Abstract] [Full Text] [Related]
20. Primary cutaneous CD4+ small-to-medium-sized pleomorphic T-cell lymphoma: a rare case report of infant.
Li D; Guo B; Li D; Chang C; Lu Q
J Clin Pathol; 2015 Oct; 68(10):855-8. PubMed ID: 26112823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
